Top Health trends
October 27, 2026
Real, editorialised trend snapshots from thousands of sources in 50 countries — updated daily, archived forever, open to everyone.
Pulse · Category
Top 6 Health — October 27, 2026
- 01
Sacituzumab Tirumotecan and Pembrolizumab
Sacituzumab tirumotecan plus pembrolizumab showed a 70.2% objective response rate in PD-L1+ NSCLC, compared to 42.0% with pembrolizumab alone.
Trending in United States - 02
Tarlatamab-Durvalumab Small Cell Lung Cancer
An immunotherapy combination of Tarlatamab and Durvalumab extends survival for patients with aggressive small cell lung cancer.
Trending in United States - 03
Gene Therapy for Muscular Dystrophy
A novel gene therapy platform has restored muscle function in a model of Duchenne muscular dystrophy. This condition primarily affects males, causing muscle damage, inflammation, and loss of walking.
Trending in United States - 04
Gut-Spine Axis and Disc Degeneration
The gut-spine axis is explored in relation to lumbar intervertebral disc degeneration, focusing on microbial and inflammatory signatures.
Trending in United States - 05
Lung cancer perioperative therapy
Biomarkers predict improved outcomes after perioperative immune-based therapy for lung cancer, as studied in NeoCOAST-2.
Trending in United States - 06
Centenarians and cardiovascular disease
A review finds that centenarians delay, but do not avoid, cardiovascular disease.
Trending in United States
See trends evolve in real time
This page is yesterday's snapshot — create a free account to see and track trends evolving in real time, discover trends before everyone else, set alerts, and even generate articles.